2022
Botulinum Toxin Treatment of Pain Disorders
Jabbari B. Botulinum Toxin Treatment of Pain Disorders. 2022 DOI: 10.1007/978-3-030-99650-5.Peer-Reviewed Original ResearchBotulinum toxin treatmentPain disordersToxin treatmentPost-traumatic neuralgiaPain medicine specialistsEvidence-based literature reviewLow back painPain syndromeAnalgesic effectPain categoriesPlantar fasciitisBack painBoNT therapyTreatment menuIllustrative case historiesMedicine specialistsAnimal studiesPainDisordersTreatmentClinical chaptersLiterature reviewFasciitisNeuralgiaInternists
2018
Botulinum Toxin Treatment of Movement Disorders
Safarpour Y, Jabbari B. Botulinum Toxin Treatment of Movement Disorders. Current Treatment Options In Neurology 2018, 20: 4. PMID: 29478149, DOI: 10.1007/s11940-018-0488-3.Peer-Reviewed Original ResearchTask-specific dystoniaMovement disordersHemifacial spasmBotulinum toxin treatmentMovement disorder expertsHigh-quality studiesAutonomic dysfunctionOromandibular dystoniaCervical dystoniaPain disordersBoNT therapyRest tremorLaryngeal dystoniaVocal ticsToxin treatmentTourette syndromeDystoniaDisorder expertsEssential tremorAmerican AcademyTherapeutic agentsFirst choiceEfficacyDisordersBlepharospasm
2017
Botulinum Toxin Treatment in Multiple Sclerosis—a Review
Safarpour Y, Mousavi T, Jabbari B. Botulinum Toxin Treatment in Multiple Sclerosis—a Review. Current Treatment Options In Neurology 2017, 19: 33. PMID: 28819801, DOI: 10.1007/s11940-017-0470-5.Peer-Reviewed Original ResearchNeurogenic detrusor overactivityMultiple sclerosisDetrusor muscleBoNT therapyMS-related trigeminal neuralgiaOpen-label clinical trialSymptoms of MSTreatment of MSEfficacy of BoNTLevel B evidenceBotulinum toxin treatmentInjection of BoNTBotulinum neurotoxin therapyClass IV studiesBladder detrusor muscleNon-MS populationPurpose of reviewNeurotoxin therapyDetrusor overactivityInternuclear ophthalmoplegiaOveractive bladderTonic spasmsLevel of efficacyTrigeminal neuralgiaClinical trials